drugset / Trial / NCT02434666

Long Term Extension Safety Study in Patients With Dementia of the Alzheimer's Type Who Completed Study CPC-001-07

NCT02434666 ↗

NaSingle-groupOpen-labelTreatment

Summary

This is a long-term-safety roll-over extension study for a Phase II Study (Protocol CPC-001-07).

Timeline

Start
2015-01-08
Primary completion
2016-10-18
Completion
2016-11-22

Drugs

EvaluationDrugModalityDoseRoute
Subject CPC-201 Unknown 15 mg —
Subject CPC-201 Unknown 20 mg —
Subject CPC-201 Unknown 60 mg —

Indications